These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 7974335

  • 61. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.
    Green D, Lechner K.
    Thromb Haemost; 1981 Jun 30; 45(3):200-3. PubMed ID: 6792737
    [Abstract] [Full Text] [Related]

  • 62. Induction of tolerance to factor VIII in a child with a high-titer inhibitor: in vitro and in vivo observations.
    Gomperts ED, Jordan S, Church JA, Sakai R, Lemire J.
    J Pediatr; 1984 Jan 30; 104(1):70-5. PubMed ID: 6418874
    [Abstract] [Full Text] [Related]

  • 63. Calculating the dose of factor VIII in the management of haemophilia.
    Ingram GI.
    Br J Haematol; 1981 Jun 30; 48(2):351-4. PubMed ID: 6786322
    [Abstract] [Full Text] [Related]

  • 64. Hemophilia prophylaxis with factor VIII concentrate.
    Kasper CK, Dietrich SL, Rapaport SI.
    Arch Intern Med; 1970 Jun 30; 125(6):1004-9. PubMed ID: 4951928
    [No Abstract] [Full Text] [Related]

  • 65. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)].
    Okubo S, Ikuma T, Hamaguchi Y, Yasunaga K.
    Rinsho Ketsueki; 1985 May 30; 26(5):701-8. PubMed ID: 3932716
    [No Abstract] [Full Text] [Related]

  • 66. [Treatment of hemophiliacs with antibodies to factor VIII].
    Evensen SA, Stavem P, Stormorken H, Glomstein A, Ly B.
    Tidsskr Nor Laegeforen; 1986 Jan 10; 106(1):35-8. PubMed ID: 3082032
    [No Abstract] [Full Text] [Related]

  • 67. Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose.
    Van Leeuwen EF, Mauser-Bunschoten EP, Van Dijken PJ, Kok AJ, Sjamsoedin-Visser EJ, Sixma JJ.
    Br J Haematol; 1986 Oct 10; 64(2):291-7. PubMed ID: 3096366
    [Abstract] [Full Text] [Related]

  • 68. [Results of a cooperative study of the clinical and therapeutic aspects of the haemophilias (author's transl)].
    Sangre (Barc); 1978 Oct 10; 23(5B):746-55. PubMed ID: 725715
    [No Abstract] [Full Text] [Related]

  • 69. [Chronic liver dysfunction in patients with hemophilia A. Effect of introduction of factor VIII concentrate].
    Kojima S, Tonouchi T, Ikegaya M, Mimaya J.
    Rinsho Ketsueki; 1984 Jan 10; 25(1):31-6. PubMed ID: 6431147
    [No Abstract] [Full Text] [Related]

  • 70. [Incidence of inhibitors in children with hemophilia A].
    Izquierdo-Ramírez J, Contreras-Mulato EL, Sotelo-Ham EI, Marín-Palomares T, Dueñas-González MT, Benítez-Aranda H.
    Bol Med Hosp Infant Mex; 1988 Sep 10; 45(9):578-82. PubMed ID: 3142496
    [No Abstract] [Full Text] [Related]

  • 71. Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C.
    Mauser-Bunschoten EP, Damen M, Reesink HW, Roosendaal G, Chamuleau RA, van den Berg HM.
    Ann Intern Med; 1996 Aug 15; 125(4):297-9. PubMed ID: 8678393
    [Abstract] [Full Text] [Related]

  • 72. Successful preoperative apheresis of factor VIII antibody using factor VIII concentrate as a replacement fluid.
    Apter B, McCarthy V, Shapiro SS, Ballas SK.
    J Clin Apher; 1986 Aug 15; 3(2):140. PubMed ID: 3084459
    [Abstract] [Full Text] [Related]

  • 73. [Study on the levels of anti-A, anti-B isoagglutinin titer in various kinds of concentrates for hemophilia treatment--with special regard to the manufacturing process of factor VIII concentrate].
    Tomita Y, Inagaki M, Taki M, Miura T, Saito N, Sato R, Meguro T, Yamada K.
    Rinsho Ketsueki; 1985 Feb 15; 26(2):166-70. PubMed ID: 3927035
    [No Abstract] [Full Text] [Related]

  • 74. Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs.
    Rizza CR, Matthews JM.
    Br J Haematol; 1982 Sep 15; 52(1):13-24. PubMed ID: 6810911
    [No Abstract] [Full Text] [Related]

  • 75. Suppression of inhibitors in haemophilia with corticoids and factor VIII.
    Aznar JA, Jorquera JI, Peiro A.
    Thromb Haemost; 1983 Jun 28; 49(3):248. PubMed ID: 6410535
    [No Abstract] [Full Text] [Related]

  • 76. Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A.
    Hathaway WE, Christian MJ, Clarke SL, Hasiba U.
    Am J Hematol; 1984 Jul 28; 17(1):85-8. PubMed ID: 6430068
    [Abstract] [Full Text] [Related]

  • 77. [Home treatment of patients with hemophilia].
    Blombäck M, Walter H, Wiechel B.
    Lakartidningen; 1979 Dec 19; 76(51):4718-21. PubMed ID: 120917
    [No Abstract] [Full Text] [Related]

  • 78. Pharmacokinetics of a new heat-treated concentrate of factor VIII estimated by model-independent methods.
    Longo G, Matucci M, Messori A, Morfini M, Rossi-Ferrini P.
    Thromb Res; 1986 May 15; 42(4):471-6. PubMed ID: 3087013
    [Abstract] [Full Text] [Related]

  • 79. Prospective study of hepatitis after factor VIII concentrate exposed to hot vapour.
    Mannucci PM, Zanetti AR, Colombo M.
    Br J Haematol; 1988 Apr 15; 68(4):427-30. PubMed ID: 3132199
    [Abstract] [Full Text] [Related]

  • 80. Dental management of the classic hemophiliac with inhibitors.
    Redding SW, Stiegler KE.
    Oral Surg Oral Med Oral Pathol; 1983 Aug 15; 56(2):145-8. PubMed ID: 6225980
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.